[ANR] YoY Quarter Result on 31-Dec-2022 [#Q2]

Stock
[ANR] Anatara Lifesciences Ltd
Announcement Date
30-Dec-2022
Financial Year
2023
Quarter
31-Dec-2022 [#Q2]
Profit Trend
QoQ- 28.55%
YoY- 19.93%
Quarter Report
ANR's Result
ANR's Financial Summary
View:
Show?
Quarter Result
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 523 273 396 319 686 417 487 1.19%
PBT -1,161 -934 -1,327 -1,494 -1,625 -2,221 -2,021 -8.81%
Tax 0 -255 -371 -300 -596 -417 0 -
NP -1,161 -679 -956 -1,194 -1,029 -1,803 -2,021 -8.81%
Tax Rate - - - - - - - -
Total Cost 1,684 952 1,352 1,513 1,715 2,221 2,508 -6.41%
Ratio Analysis
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin -221.89 -249.02 -241.39 -374.50 -150.15 -432.09 -415.32 -9.91%
Per Share
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS -0.01 -0.01 -0.01 -0.02 -0.01 -0.03 -0.04 -20.61%
EPS Diluted -0.01 -0.01 -0.01 -0.02 -0.01 -0.03 -0.04 -20.61%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.